CBD may help rebuild brain connections by acting as “molecular glue,” offering a new path for Alzheimer’s treatment research.

Rachel Carr Shreves and Crystal Howard of Spencer Fane discuss the proposed federal rescheduling of cannabis to Schedule III ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will present six abstracts, including one oral presentation, at the 2026 American Academy of Neurology (AAN) Annual Meeting, ...

The order instructs the FDA to expedite review of drugs such as ibogaine, a drug that veterans' groups have said can help ...

A Neuropsychopharmacology Circumspectives article argues that cannabidiol has genuine therapeutic potential, especially in ...

New research has found that teenagers who use cannabis may experience slower gains in thinking and memory skills as they grow ...

A string of ASX-listed drug developers is due to release company-making – or breaking – pivotal clinical study results in ...

Youth cannabis use between ages 9 and 17 years is associated with slower cognitive development during a time of key brain ...

“Our study provides a comprehensive and independent assessment of the benefits and risks of cannabis medicines, which may ...

We agree with the Administration’s recognition that the mental health crisis in America demands a new level of regulatory urgency and scientific ambition,” commented Incannex CEO Joel Latham. ”For ...

A law that introduced new tax rates, age restrictions, penalties and licensure requirements for THC hemp-derived products in ...